Skip to main content

Table 1 75 genes involved in AD enriched pathways

From: Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease

PathwayGenesTotal
Immune response-Alternative complement pathwayC3, CD46, CD55, CD59, CLU, CR1, ITGAM, ITGAX8
Development-Neurotrophin family signalingMAPK3, BAX, BRAF, GAB1, GRB2, HRAS, JUN, MAGED1, MAP2K1, MAP2K2, MAP3K1, MAPK1,MAPK8, PIK3R1, PIP5K1A, PTPN11, RAC1, RAF1, RAP1A, RAPGEF1, SHC1, SORT1, SOS1, TP53,AK125
Neurophysiological process-NMDA-dependent postsynaptic long-term potentiation in CA1 hippocampal neuronsAKT1, BRAF, CALM1, CREB1, EIF4E, GRB2, HRAS, MAP2K1, MAP2K2, MAPK1, MAPK3, MKNK1, PIK3R1, PRKACA, RAP1A, RAPGEF3, RPS6KA1, RPS6KB1, SHC1, XYLT220
Cell adhesion-Ephrin signalingADAM10, CDC42, EPHA1, EPHB1, FYN, GRB10, HRAS, KALRN, MAP3K7, MAP4K4, MAPK8, NCK1, NCK2, PAK1, PXN, RAC1, RAF1, RAP1A, RASA1, RHOA, SLA, SLC10A3, SRC, GRB224
Neurophysiological process-nNOS signaling in neuronal synapsesCALM1, CALM2, CALM3, DLG4, GRIN2C, GRINA, PPP3CA PPP3CB, PPP3CC, PPP3R1, PRKCB, PRKCD, PRKCH, PRKCI, PRKD315